OCC

1.61%

61.0¢ orthocell limited

Ann: Orthocell Appoints Non-Executive Director Dr Ravi Thadhani, page-24

First 24 Last

Share
Profile

Follow
ridethewave01

31 Posts.

4

08/03/23

19:34

Post #: 66665337
Share

Originally posted by bedger: ↑

I have been called a ramper and a defender of management over the years on Hot Copper. To keep it short, I see the science and products/therapies as brilliant, but the management of this company (bar Bio Horizons deal) as average at best. A copy of the email I sent to executives today:

"A great addition to the Board, but really? Options with a strike price of $0.40?

What is going on with OCC? You guys pull a Bio Horizons deal absolutely out of the bag against the odds, but dawdle on Remplir for 2 years and then give out options that completely fail to incentivize a newcomer to the Board.

A little reminder of how Directors should be designing employee and directors' (executive or otherwise), remuneration packages from the Australian Institue of DIrectors:

https://www.pc.gov.au/inquiries/completed/executive-remuneration/submissions/sub059-part9.pdf

"Equity plans serve to align the interests of executives with shareholders by providing direct participation in the benefits of future company performance. The structure of these plans as a whole, including the level of entitlement, performance measures and time periods before entitlement to rewards, should be designed to meet the particular needs of the company in terms of driving improved company performance".

Granting significant options with an "at the money" strike price, absolutely, does not do that. Literally where the stock is trading, and sadly the exact IPO price nearly a decade after listing, is insulting to shareholders. Another significant diluting award that does not even incentivize the new Director to improve the share price.

Come on guys? With respect, when are you going to start acting with very specific aim to provide returns to the shareholders who have funded the continued existence of the business for the last 9 years? As I write there have net been none, other than further share award grants to insider/Board shareholders."

I suggest other shareholders CIVILLY write to express their dissatisfaction with such cronyism that continues at a Board level (alas endemic to many listed companies). I fear I have long ago lost any good will with my repeated behests to improve company communication in the past.

Expand

I have contacted them today based on the news today. Assuming I get a reply I will share it.

OCC Price at posting: 39.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

Reply

Top Stories

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Making money: How many microcaps should be in an investor's portfolio?

What each US election outcome would mean for Australian companies & investors

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

First 24 Last

Add OCC (ASX) to my watchlist

(20min delay)
Last 61.0¢		Change -0.010(1.61%)		Mkt cap ! $145.8M

Open	High	Low	Value	Volume
62.5¢	63.0¢	61.0¢	$1.181M	1.913M

Buyers (Bids)

No.	Vol.	Price($)
2	5445	61.0¢

Sellers (Offers)

Price($)	Vol.	No.
62.0¢	10000	1

View Market Depth

No.	Vol.	Price($)
2	5445	0.610
12	194149	0.605
23	290517	0.600
5	120224	0.590
2	46005	0.585

Price($)	Vol.	No.
0.620	10000	1
0.625	33152	2
0.630	68300	3
0.635	25000	1
0.640	20000	1

Last trade - 16.10pm 01/11/2024 (20 minute delay)

OCC (ASX) Chart

Ann: Orthocell Appoints Non-Executive Director Dr Ravi Thadhani, page-24

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Making money: How many microcaps should be in an investor's portfolio?

What each US election outcome would mean for Australian companies & investors

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Orthocell Appoints Non-Executive Director Dr Ravi Thadhani, page-24

Top Stories

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Making money: How many microcaps should be in an investor's portfolio?

What each US election outcome would mean for Australian companies & investors

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News